Analyst: Trulieve Stock Could Double and Then Some
Trulieve Cannabis (OTC: TCNNF), the relatively successful Florida-based marijuana company, was an investor favorite Friday. That was due in no small part to a glowing new research note from noted pot industry analyst Pablo Zuanic of Cantor Fitzgerald. In his analysis, Zuanic raised his price target to $89 per share -- a stunning 114% higher than the company's most recent closing stock price.
It almost goes without saying that the prognosticator is maintaining his overweight (buy, in other words) recommendation on Trulieve stock.
Image source: Getty Images.
Source Fool.com
